Genetics

Genetic insights that reveal risks and connections

Genetics Lab Technician Gloves 10

GENETIC DIAGNOSTIC EXPERTISE

Genetic insights to support personalised care

When a clinical question involves inherited risk, complex diagnosis, treatment response or reproductive planning, you need clear, clinically relevant genetic information.

Our genetics teams support you with testing, counselling and expert interpretation across routine and complex cases. By integrating genetic insights with pathology, radiology and laboratory data, we help provide a more complete clinical picture and support confident decision-making.

Genetics at a glance

Our genetics portfolio supports inherited risk assessment, diagnosis, treatment decisions, reproductive health and follow-up across a broad range of clinical questions.

Signatera™ for molecular residual disease monitoring
Liquid biopsy for blood-based tumour profiling
BladderCare™ for bladder cancer follow-up
Pharmacogenetics for medication response questions
SIGNATERA™ MRD MONITORING

Signatera™ for molecular residual disease monitoring

Signatera™ is a personalised, tumour-informed ctDNA test designed to support molecular residual disease monitoring in selected solid tumours.

By tracking tumour-specific DNA signals in the blood over time, it can provide additional molecular information for recurrence risk assessment, treatment-response monitoring and follow-up discussions where clinically appropriate.

NGS-BASED CTDNA LIQUID BIOPSY

Liquid biopsy for blood-based tumour profiling

NGS-based ctDNA liquid biopsy analyses tumour-derived DNA fragments circulating in the blood to identify clinically relevant genomic alterations.

It can support molecular profiling in selected advanced solid tumours, particularly when tissue is insufficient or not feasible, and may provide additional information for treatment planning, response monitoring or disease evolution.

BLADDERCARE™ UROLOGICAL CANCER DIAGNOSTICS

BladderCare™ for bladder cancer follow-up

BladderCare™ is a urine-based genomic test that can support the monitoring of non-muscle invasive bladder cancer.

It provides molecular information that may help physicians assess recurrence risk and support follow-up decisions alongside cystoscopy, cytology and clinical evaluation.

PHARMACOGENETICS

Pharmacogenetics for medication response questions

Pharmacogenetic testing analyses selected genetic variants that may influence how a patient responds to certain medications.

The results can support physicians when considering treatment choice, dosage or follow-up, particularly when drug response, metabolism or tolerability are clinically relevant.

Swipe to find out more
Genetics Lab Technician Gloves Tube Rack 6

WHY UNILABS

Why choose Unilabs for genetic diagnostics?

Unilabs supports healthcare professionals with genetic testing, specialist interpretation and counselling support across routine and complex clinical questions.

  • Right test: Support in selecting the appropriate test, assessing the indication and determining the diagnostic approach.

  • Clinical interpretation: Interpretation of genetic variants in the context of the specific clinical question.

  • Methods tailored to your needs: NGS, Sanger sequencing, genotyping and cytogenetic methods depending on the clinical situation.

  • Connected diagnostics: Integration with pathology, radiology and laboratory medicine when required by the clinical context.


GENETIC COUNSELLING & INTERPRETATION

Support for genetic results and patient communication

Genetic results can influence diagnosis, treatment decisions and family risk. When needed, our genetics experts and genetic counsellors support test selection, result interpretation and communication with patients and relatives.

Find your expert

Find the right specialist for your needs.

Need diagnostic support? Our team is here to help you find the right services, tests or expertise for your practice.